Quantcast
Last updated on April 16, 2014 at 13:15 EDT

Latest Organofluorides Stories

2013-12-04 23:04:21

The Lipitor diabetes lawsuit is One of Dozens Currently Pending in U.S. Courts that Claim the Cholesterol-Lowering Drug Increases the Risk for Type 2 Diabetes. Columbus, OH (PRWEB) December 04, 2013 Wright & Schulte LLC has learned that a woman from West Virginia recently filed a new Lipitor diabetes lawsuit alleging that the use of the cholesterol-lowering statin caused her to develop new-onset Type 2 diabetes. According to a November 6th report from the West Virginia Record, the...

2013-12-04 12:23:25

The Strongest Dynamic Decreasing Sales in the HIV Market is Generic Erosion of Key Antiretroviral Drugs, According to a New Report from Decision Resources BURLINGTON, Mass., Dec. 4, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that major-market sales of antiretroviral (ARV) drugs for HIV will decrease marginally over the next decade, from an estimated $13.4 billion in 2012 to $13.1...

2013-12-03 23:32:27

Federal judge schedules key trial date from hundreds of cases from across the country.Resource4thePeople's national network of attorneys continues to provide free consultations to families with children allegedly suffering birth defects after use of SSRIs during pregnancies. San Diego, CA (PRWEB) December 03, 2013 http://www.resource4thepeople.com/defectivedrugs/SSRI-Birth-Defects.html Resource4thePeople announced today its latest update for consumers who have been following the...

2013-12-03 23:00:51

The Firm is investigating legal claims on behalf of alleged victims of Risperdal and gynecomastia, or male breast growth. New York, New York (PRWEB) December 03, 2013 Hundreds of Risperdal lawsuits (http://www.risperdallawsuitcenter.com/), including many that allege a link between Risperdal and gynecomastia (male breast growth), continue to move forward in a consolidated litigation underway in the Pennsylvania Court of Common Pleas in Philadelphia. According to a Motion filed on November...

2013-12-03 16:22:00

DUBLIN, Ireland, December 3, 2013 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/zp75jd/1122tetrafluor) has announced the addition of the "1,1,2,2-Tetrafluoroethane (CAS 359-35-3) Market Research Report 2012" [http://www.researchandmarkets.com/research/zp75jd/1122tetrafluor ] report to their offering. <start_newscom> (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) 1,1,2,2-TETRAFLUOROETHANE (CAS 359-35-3) Market...

2013-12-02 23:03:05

Reportbuyer.com just published a new market research report: In-Depth Research and Development Forecast of China Fluorine Chemical Industry, 2013-2017. London (PRWEB) December 02, 2013 After more than 80 years of development, the world fluorine chemical industry has become one of the relatively mature chemical industries; the sales of the global fluorides has exceeded USD 23 billion and the average growth rate is 3.8% for recent five years. At present, by virtue of monopoly business and...

2013-11-29 23:04:37

The Firm is investigating Risperdal lawsuits on behalf victims of gynecomastia, or male breast growth, allegedly associated with use of the drug. New York, New York (PRWEB) November 29, 2013 As Risperdal lawsuits (http://www.risperdallawsuitcenter.com/ ) continue to move forward in courts around the country, Bernstein Liebhard LLP notes that the federal government has granted a substantial award to a whistleblower who provided the U.S. Department of Justice with important information...

2013-11-27 08:25:33

Editor Note: For more information about this release, please scroll to bottom. NEW YORK, November 27, 2013 /PRNewswire/ -- Today, Analysts' Corner announced new research reports highlighting Bristol-Myers Squibb Company (NYSE: BMY), Ariad Pharmaceuticals Inc. (NASDAQ: ARIA), Dyax Corp. (NASDAQ: DYAX), Ironwood Pharmaceuticals Inc. (NASDAQ: IRWD), and Immunomedics Inc. (NASDAQ: IMMU). Today's readers may access these reports free of charge - including full price targets,...

2013-11-26 23:30:44

Spartan Bioscience announces 2,000-patient clinical trial of rapid DNA testing for heart attack patients using antiplatelet drugs. Ottawa, Ontario (PRWEB) November 26, 2013 Spartan Bioscience today announced the start of a 2,000-patient study of personalized medicine for cardiac stent patients in Saudi Arabia. The study is sponsored by the University of Dammam, and is entitled “Bedside Testing of CYP2C19 Gene for Treatment of Patients with PCI with Antiplatelet Therapy.” The Spartan...

2013-11-24 23:01:52

The Firm is now investigating Risperdal lawsuits on behalf of men and boys who developed gynecomastia (male breast growth), allegedly due to Risperdal. New York, New York (PRWEB) November 24, 2013 As Risperdal lawsuit claims alleging an association between use of the antipsychotic drug and gynecomastia, or male breast growth, continue to move forward in courts throughout the country, Bernstein Liebhard LLP announces that it has launched a new Risperdal lawsuit website...